380P Assessing interstitial lung disease (ILD) risk in metastatic breast cancer (MBC): A comprehensive meta and network analysis of antibody-drug conjugates (ADCs) compared to available treatment options beyond first-line (1L).
Saved in:
| Title: | 380P Assessing interstitial lung disease (ILD) risk in metastatic breast cancer (MBC): A comprehensive meta and network analysis of antibody-drug conjugates (ADCs) compared to available treatment options beyond first-line (1L). |
|---|---|
| Authors: | Cucciniello, L.1 (AUTHOR), Giudici, F.2 (AUTHOR), Di Nardo, P.1 (AUTHOR), Dri, A.1 (AUTHOR), Della Rossa, S.1 (AUTHOR), Zottarelli, E.1 (AUTHOR), Noto, C.3 (AUTHOR), Foffano, L.1 (AUTHOR), Pastò, B.1 (AUTHOR), Bolzonello, S.4 (AUTHOR), Da Ros, L.1 (AUTHOR), Cudia, G.5 (AUTHOR), Nascimbeni, E.5 (AUTHOR), Lisanti, C.1 (AUTHOR), Spazzapan, S.1 (AUTHOR), Serraino, D.2 (AUTHOR), Gerratana, L.6 (AUTHOR), Puglisi, F.7 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS378-S378. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
